Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Reporting of Financial Conflicts of Interest in Meta-Analyses of Pharmacological Treatment Trials: A Cross-sectional Study
EF 2018-19
Résumé
Financial conflicts of interest (COI) are present in situations where a financial interest has the potential to influence a primary interest, for example evaluating the effectiveness of a drug. Systematic reviews and meta-analyses synthesize information from multiple studies and are considered one of the strongest sources of scientific evidence. The failure to report financial COI from the studies included in systematic reviews and meta-analyses may lead readers to believe that COI were not present or not important. As a result, readers are prevented from determining whether financial COI may have influenced the findings. Previous studies have shown that systematic reviews and meta-analyses of drugs often fail to report COI from included randomized controlled trials. However, these studies were conducted in 2011-2012 and examined high-impact journals, which are known for their rigor, and may not be representative of reporting practices more generally or of current practices. The objectives of my project are to (1) evaluate the extent to which meta-analyses of drugs report COI from included trials in large sample not restricted to high impact journals and (2) to examine factors associated with reporting COI from trials included in meta-analyses. To achieve this, I will extract data on factors that may influence whether COI from included trials are reported, such as meta-analysis funding sources and journal impact factor. Following this, variables will be entered into a regression model to determine which factors are associated with the reporting of COI from included trials. This study has the potential to improve medical decision-making by helping researchers and health care professionals to accurately assess the potential for bias from COI in meta-analyses.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406628
Name
Turner Kimberly A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Reporting of Financial Conflicts of Interest in Meta-Analyses of Pharmacological Treatment Trials: A Cross-sectional Study
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bias; Conflict Of Interest; Drug; Financial Conflict Of Interest; Meta-Anlysis; Meta-Research; Pharmacotherapy; Systematic Review
Abstract
Financial conflicts of interest (COI) are present in situations where a financial interest has the potential to influence a primary interest, for example evaluating the effectiveness of a drug. Systematic reviews and meta-analyses synthesize information from multiple studies and are considered one of the strongest sources of scientific evidence. The failure to report financial COI from the studies included in systematic reviews and meta-analyses may lead readers to believe that COI were not present or not important. As a result, readers are prevented from determining whether financial COI may have influenced the findings. Previous studies have shown that systematic reviews and meta-analyses of drugs often fail to report COI from included randomized controlled trials. However, these studies were conducted in 2011-2012 and examined high-impact journals, which are known for their rigor, and may not be representative of reporting practices more generally or of current practices. The objectives of my project are to (1) evaluate the extent to which meta-analyses of drugs report COI from included trials in large sample not restricted to high impact journals and (2) to examine factors associated with reporting COI from trials included in meta-analyses. To achieve this, I will extract data on factors that may influence whether COI from included trials are reported, such as meta-analysis funding sources and journal impact factor. Following this, variables will be entered into a regression model to determine which factors are associated with the reporting of COI from included trials. This study has the potential to improve medical decision-making by helping researchers and health care professionals to accurately assess the potential for bias from COI in meta-analyses.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Turner, Kimberly A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~